NEDD4L and diabetic retinopathy: In addition, pharmacological or genetic promotion of NEDD4L may represent a promising therapeutic strategy for treating ischemic diseases, such as myocardial infarction, exacerbates diabetic retinopathy and critical limb ischemia, by promoting angiogenic role in the ischemic tissues.